New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...

New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...

PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...

PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...

PORT WASHINGTON, New York, Nov. 27, 2018 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced it will ...

Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...

NEW YORK, Sept. 8, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese ...